DNA Script Exclusively Licenses baseclick GmbH Technology
DNA Script Exclusively Licenses baseclick GmbH Technology to Enable Benchtop Printing of Modified DNA On‐Demand
PARIS and SOUTH SAN FRANCISCO, Calif., & NEURIED, Germany, February 23, 2021 — DNA Script, SAS, a leading pioneer in enabling DNA synthesis on demand, and baseclick GmbH announced today an exclusive licensing agreement that grants DNA Script use of the novel “Click” chemistry commercialized by baseclick. In effect, this agreement enables DNA Script’s customers to enzymatically synthesize high purity nucleic acids with modifications using their SYNTAX™ DNA printing system.